Let's say a clinic currently has eleven doctors and is able to treat X number of patients per week. Let's say one of them retires, and instead of finding a human replacement, the remaining ten doctors choose an AI clinical assistant to free up 10% of their workload. Now it only takes ten AI-assisted doctors to continue serving the same number of patients as eleven doctors used to do.
This is just an example to show that there is no meaningful difference between "assisting" and "replacing". Any time an assistant, AI or not, takes some workload off somebody's plate, they have partially replaced them, and it adds up.
This isn’t even considering quality of care, only quantity.
For other professions, if there’s already a glut of supply,… well, we don’t really need more ads or reality tv shows or sensational/viral clickbait.
2. If a clinic can use an AI tool to make doctors 10% more productive, doctors become worth more rather than less. Firms are incentivized to hire more rather than less in this scenario. What you're invoking here is the "lump of labor" fallacy. There are market conditions where increasing efficiency really does reduce quantity demanded, but it's not clear that medicine really is one. As far as I can tell, far from there being a fixed lump of medical work, the general population in most of the West is under-serviced and struggles to get reliable, timely, cost-effective access to medical expertise.
We saw this play out in agriculture, in manufacturing, and now it is starting to happen in some services. I do not understand why would we think it will be any different this time around.
The thing you're missing here is that "healthcare services" and "doctor's labor" aren't the same unit. Ceteris paribus, efficiency increases allow the price of healthcare to decrease while the price of doctor's labor increases. The thing that makes this non-contradictory is that a single doctor can now produce "more" healthcare. Economics says the opposite of what you think it does here. Increasing productivity drives expansion in market size, which drives up the ratio of value in the market to its labor inputs which drives up salaries.
Like I said, there might be important real-world reasons why these scenarios won't play out in medicine the way the theory predicts. But so far, you haven't provided any.
Manufacturing has also seen the opposite of what you are saying here. Global manufacturing production value has exploded over the last century, quite literally lifting billions of people out of abject poverty. In particular the last 3 decades of enormous per capita income increases in China have been driven by industrialization. I'm guessing you're taking a US-centric view that is exclusively focused on the local collapse of US manufacturing. This is to do with globalization and free trade, not improvements to labor efficiency.
If the AI can't do all the things that a doctor can do, then even when it can take up the slack for one doctor retiring, that doesn't tell you anything at all about whether or not it can take up the slack for two retiring.
Right now there's more work to be done than there are doctors to do it; this means that the same number of doctors are getting more things done as the AI improves… but not infinitely more, because there's still stuff the current AI can't do, that only humans can do.
We have a lot of things where technology has fully saturated demand: in food, this is why we've got an obesity problem in much of the world[0]; in medicine, this is how we wiped out smallpox entirely, and are very close to wiping out a few other diseases entirely; in telephony, this is why video conference calls are basically free.
But in each of those fields, there are other things we still have demand for, they're not complete post-scarcity: restaurants, old age, and bandwidth costs are still a thing.
[0] not so for transport, which is one reason why we simultaneously have some people starving
There are quite good specialized systems for medical applications that were thoroughly tested and vetted against quite high barriers for entry.
I hate the approach of ad companies to approach medical problems. Of course you need patient data for clinical studies, but far more interesting would be to collect data that hint to medical indications and offering up this knowledge to doctors that cannot know about all of them.
LLMs probably will just grow a new generation of hypochondriacs because they certainly will never say that you are healthy if diagnostic supports ever make it into production.